Price target 30 cent https://biotuesdays.com/2019/09/26/hcw-ups-bionomics-to-buy-pt-to-30-cents-from-3-cents/ Gap up Monday
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%